Disease: Richter syndrome
- <em>TP53</em> mutation is a high-risk factor for Richter's syndrome based on circulating tumor DNA
- A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation
- A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome
- A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter's syndrome
- A virus and its consequences: COVID-19 and Long Covid - A hybrid disease model
- Acid-sensing ion channel 3 mediates pain hypersensitivity associated with high-fat diet consumption in mice
- Adverse Events After Isolated Posterior Cruciate Ligament Reconstruction: A National Database Study
- An extranodal Richter's syndrome presenting with cardiac diffuse large B-cell lymphoma: a case report
- Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study
- Antibiotic prophylaxis for onabotulinum toxin A injections: systematic review and meta-analysis
- Are informants required to obtain valid ratings on the Positive and Negative Syndrome Scale (PANSS)?
- Are we closer to a standard of care for Richter's syndrome? Novel treatments on the horizon
- Association of 5-Year Hip Arthroscopy Outcomes with Hip Morphology and Cartilage Status at Time of Surgery: A National Registry Study With HAGOS Outcomes in 281 Patients With Femoroacetabular Impingement Syndrome
- Autoimmunity and Autoinflammation: Relapsing Polychondritis and VEXAS Syndrome Challenge
- Beyond the Umbrella: A Systematic Review of the Interventions for the Prevention of and Reduction in the Incidence and Severity of Ovarian Hyperstimulation Syndrome in Patients Who Undergo In Vitro Fertilization Treatments
- Cangrelor - Expanding therapeutic options in patients with acute coronary syndrome
- Cardiac dysfunction in severe pediatric acute respiratory distress syndrome: the right ventricle in search of the right therapy
- CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis
- CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study
- Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
- Changes in Doppler-Derived Kidney Venous Flow and Adverse Cardiorenal Outcomes in Patients With Heart Failure
- Changes in immunoglobulin levels during clozapine treatment in schizophrenia
- Clinical Features, Incidence and Treatment Outcome in Pregnancy-Associated Osteoporosis: A Single-Centre Experience over Two Decades
- Cognitive behavioural therapy without medication for schizophrenia
- Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses
- Cortical morphology variations during the menstrual cycle in individuals with and without premenstrual dysphoric disorder
- Decreased circulating CTRP3 levels in acute and chronic cardiovascular patients
- Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
- Development, piloting and evaluation of an app-supported psychosocial prevention intervention to strengthen participation in working life: a study protocol of a mixed-methods approach
- Diagnostic accuracy of oral glucose tolerance tests, fasting plasma glucose and haemoglobin A1c for type 2 diabetes in women with polycystic ovary syndrome: A systematic review and meta-analysis
- Diffusion tensor-based analysis of white matter in dogs with idiopathic epilepsy
- Distinct multimodal biological and functional profiles of symptom-based subgroups in recent-onset psychosis
- Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria
- Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
- Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
- Elevated Anti-Mullerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary Syndrome
- Endothelial Glycocalyx Degradation Patterns in Sepsis-Associated Pediatric Acute Respiratory Distress Syndrome: A Single Center Retrospective Observational Study
- Epcoritamab, a promising therapy for Richter syndrome?
- Epidemiology of 7375 children and adolescents hospitalized with COVID-19 in Germany, reported via a prospective, nationwide surveillance study in 2020-2022
- EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
- Evaluation and management of patients with coronary chronic total occlusions considered for revascularisation. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the European Associa
- Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023
- Factorial validity and comparability of the six translations of the Rivermead Post-Concussion Symptoms Questionnaire translations: results from the CENTER-TBI study
- First Confirmed Case of Canine Mortality Due to Dihydroanatoxin-a in Central Texas, USA
- FMRP deficiency leads to multifactorial dysregulation of splicing and mislocalization of MBNL1 to the cytoplasm
- FMRP regulation of aggrecan mRNA translation controls perineuronal net development
- Genetics and etiology of congenital heart disease
- Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy
- Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
- High-sensitivity cardiac troponin I for cardiovascular risk stratification in apparently healthy individuals
- Ibrutinib (Imbruvica): CADTH Reimbursement Recommendation: Indication: Ibrutinib in combination with venetoclax for the treatment of adult patients with previously untreated chronic lymphocytic leukemia, including those with 17p deletion [Internet]
- Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort
- Imaging findings of traumatic injuries in survivors of the 6 February 2023 earthquake in Turkey
- Interdisciplinary multimodal pain therapy in postviral syndromes and ME/CFS : Features, pitfalls and model concept
- Intracellular signaling pathways of muscarinic acetylcholine receptor-mediated detrusor muscle contractions
- Kidney function and transplants in prune belly syndrome: a scoping review
- Long-term remission in a patient with relapsed Richter's transformation treated with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell transplantation
- Longitudinal Predictors of Word Reading for Children with Williams Syndrome
- Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies
- Mpox infection protects against re-challenge in rhesus macaques
- Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia
- Neurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients
- Noninvasive diagnostic imaging for endometriosis part 2: a systematic review of recent developments in magnetic resonance imaging, nuclear medicine and computed tomography
- Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY
- Postcardiotomy Shock Syndrome: A Narrative Review of Perioperative Diagnosis and Management
- Predicting COVID-19 Incidence Using Wastewater Surveillance Data, Denmark, October 2021-June 2022
- Prognostication in chronic lymphocytic leukemia
- Psychosocial wellbeing shortly after allocation to a freeze-all strategy compared with a fresh transfer strategy in women and men: a sub-study of a randomized controlled trial
- Quality of life in men with Klinefelter Syndrome - a multicentre study
- Radiological management and challenges of the twin earthquakes of February 6th
- Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia
- Real-world practices of hormone monitoring during ovarian stimulation in assisted reproductive technology: a global online survey
- Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†
- Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis
- Response to therapy in Richter syndrome: a systematic review with meta-analysis of early clinical trials
- Response-Adapted, Time-Limited Venetoclax, Umbralisib and Ublituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia
- Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia
- Richter Syndrome Presenting as Subcutaneous Nodules and a Dermal Plaque
- SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
- Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity
- Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone
- Teclistamab for Multiple Myeloma: Clinical Insights and Practical Considerations for a First-in-Class Bispecific Antibody
- The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilization
- The molecular map of CLL and Richter's syndrome
- The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation
- The prevalence of frailty and its effect on the outcome in cardiac resynchronization therapy patients
- The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS
- TP53 mutation is a high-risk factor for Richter's syndrome based on circulating tumor DNA
- Trabecular bone density in middle-aged women with reproductive disorders
- Treatment of Richter's Transformation with Novel Therapies
- Treatment of schizophrenia evaluated via the pharmacopsychometric triangle-An integrative approach with emphasis on well-being and functioning
- Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021
- Validation of an Anti-Mullerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study
- Validation of the ICEBERG emergency room screening tool for early identification of older patients with geriatric consultation needs
- Variation of modulation and expression of biomarkers associated with inflammation in bariatric surgery patients: A systematic review and meta-analysis
- ZNF683 marks a CD8(+) T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome
- ZNF683 marks a CD8<sup>+</sup> T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome